1. Dorey SE, Neveu MM, Burton LC, et al. The clinical features of albinism and their correlation with visual evoked potentials. Br J Ophthalmol. 2003; 87:767–72.
Article
2. Susan MC, Raymond EB, Pamela JS, William VG. Albinism:modern molecular diagnosis. Br J Ophthalmol. 1998; 82:189–95.
3. King RA, Pietsch J, Fryer JP, et al. Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype. Hum Genet. 2003; 113:502–13.
4. Guillery RW. Why do albinos and other hypopigmented mutants lack normal binocular vision, and what else is abnormal in their central visual pathway? Eye. 1996; 10:217–21.
5. Kim MH. Two cases of complete generalized albinism. J Korean Ophthalmol Soc. 1976; 17:150–63.
6. Park JC, Lee JH. Two cases of ocular albinism. J Korean Ophthalmol Soc. 1980; 21:271–3.
7. Lee KY, Ban MS, Song BR, Yoo JH. A case of oculocutaneous albinism. J Korean Ophthalmol Soc. 2000; 41:288–93.
8. Campochiaro PA, KAden IH, Vidaurri-Leal J, Glaser BM. Cryotherapy enhances intravitreal dispersion of variable pigment epithelial cells. Arch Ophthalmol. 1985; 103:434–6.
9. Wilkinson CP, Rice TA. Michels retinal detachment. 2nd ed.St Louis: Mosby;1997. p. 1067.
10. McDonald HR. Diagnostic and therapeutic challenges. Retina. 2001; 21:367–70.
Article